Biologics Logistics Rapidly Adopt Insulated EPP Formats
Pharmaceutical logistics providers facing expanding temperature-sensitive biologics distribution across major healthcare markets are increasingly specifying insulated EPP containers with documented thermal performance and reuse-cycle testing, rather than the conventional standard EPP tote that dominated pharmaceutical logistics when insulation requirements were less widespread in prior years. This shift commands meaningfully higher unit cost than conventional standard format given the enhanced insulation lamination and testing requirements involved. Converters report insulated orders now outpacing standard orders across several major pharmaceutical logistics accounts tracked this cycle, a clear reversal from just a few years earlier.
Market Impact: Drives roughly 5% of demand








